Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.

[1]  Mitchell Kronenberg,et al.  CD1 mediated T cell recognition of glycolipids. , 2007, Current opinion in structural biology.

[2]  P. Savage,et al.  Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids , 2007, Nature Chemical Biology.

[3]  Natalie A. Borg,et al.  CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor , 2007, Nature.

[4]  D. Godfrey,et al.  Control points in NKT-cell development , 2007, Nature Reviews Immunology.

[5]  Suvarn S. Kulkarni,et al.  Efficient, one-pot syntheses of biologically active α-linked glycolipids , 2007 .

[6]  M. Kronenberg,et al.  The unique role of natural killer T cells in the response to microorganisms , 2007, Nature Reviews Microbiology.

[7]  G. Besra,et al.  The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation , 2007, The Journal of experimental medicine.

[8]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[9]  I. Wilson,et al.  Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria , 2006, Nature Immunology.

[10]  M. Tsuji.  Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands , 2006, Cellular and Molecular Life Sciences CMLS.

[11]  I. Wilson,et al.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Y. Seto,et al.  Confirmation of the Anomeric Structure of Galacturonic Acid in the Galacturonosyl‐Ceramide of Sphingomonas yanoikuyae , 2006, Microbiology and immunology.

[13]  K. Furusawa,et al.  Efficient stereocontrolled synthesis of sphingadienine derivatives , 2005 .

[14]  A. Fersht,et al.  The crystal structure of human CD1d with and without α-galactosylceramide , 2005, Nature Immunology.

[15]  I. Wilson,et al.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor , 2005, Nature Immunology.

[16]  R. Brutkiewicz,et al.  Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d‐specific ligands for NKT cells , 2005, European journal of immunology.

[17]  I. Wilson,et al.  Anatomy of CD1–lipid antigen complexes , 2005, Nature Reviews Immunology.

[18]  D. Ho,et al.  Recognition of bacterial glycosphingolipids by natural killer T cells , 2005, Nature.

[19]  B. Beutler,et al.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[20]  Archana Khurana,et al.  The Mouse CD1d Cytoplasmic Tail Mediates CD1d Trafficking and Antigen Presentation by Adaptor Protein 3-Dependent and -Independent Mechanisms1 , 2005, The Journal of Immunology.

[21]  G. Besra,et al.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[23]  G. Besra,et al.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. So,et al.  Straightforward synthesis of sphinganines via a serine-derived Weinreb amide. , 2004, The Journal of organic chemistry.

[25]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[26]  N. Nagarajan,et al.  The Adaptor Protein AP-3 Is Required for CD1d-Mediated Antigen Presentation of Glycosphingolipids and Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.

[27]  Y. Seto,et al.  Occurrence of an alpha-galacturonosyl-ceramide in the dioxin-degrading bacterium Sphingomonas wittichii. , 2002, FEMS microbiology letters.

[28]  T. Yamamura,et al.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.

[29]  B. Lindner,et al.  Structural analysis of a new glycosphingolipid from the lipopolysaccharide-lacking bacterium Sphingomonas adhaesiva. , 2001, Carbohydrate research.

[30]  S. Francoeur,et al.  New Family of Cyclopropanating Reagents: Synthesis, Reactivity, and Stability Studies of Iodomethylzinc Phenoxides. , 2001 .

[31]  A. Kulkarni,et al.  Glycolipid antigen processing for presentation by CD1d molecules. , 2001, Science.

[32]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[33]  U. Zähringer,et al.  Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. , 2000, European journal of biochemistry.

[34]  M. Kronenberg,et al.  Binding and Antigen Presentation of Ceramide-Containing Glycolipids by Soluble Mouse and Human Cd1d Molecules , 1999, The Journal of experimental medicine.

[35]  T. Raynham,et al.  A Simplified Route to the (R)-Garner Aldehyde and (S)-Vinyl Glycinol , 1998 .

[36]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[37]  H. Flad,et al.  Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells , 1995, Infection and immunity.

[38]  T. Natori,et al.  Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. , 1995, Journal of medicinal chemistry.

[39]  E. Rietschel,et al.  Chemical structure of glycosphingolipids isolated fromSphingomonas paucimobilis , 1991, FEBS letters.

[40]  G. Chittenden.  A simplified synthesis of α-d-galactopyranose 1,3,4,6-tetraacetate , 1988 .

[41]  L. Anderson,et al.  O-Benzylated thio sugars. Derivatives of 2,3,6-tri-O-benzyl-1-thio-d-galactopyranose suitable for use in oligosaccharide synthesis , 1977 .

[42]  Suvarn S. Kulkarni,et al.  Efficient, one-pot syntheses of biologically active alpha-linked glycolipids. , 2007, Chemical communications.

[43]  M. Kronenberg,et al.  Activation of natural killer T cells by glycolipids. , 2006, Methods in enzymology.

[44]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.